|
Delayed
Nasdaq
04:28:17 31/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 3.245 USD | -7.02% |
|
+12.67% | -74.55% |
| 29/10 | Scienture Holdings, Inc. - Shareholder/Analyst Call | |
| 13/10 | Scienture Holdings, Inc. Reports Preliminary, Unaudited Revenue Results for the Third Quarter Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Pharmaceuticals Wholesale
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.73M | - | - | - | ||
| 1,224B | |||||
| 662B | |||||
| 514B | |||||
| 388B | |||||
| 361B |
Select your edition
All financial news and data tailored to specific country editions
